Patrizia Giannoni

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

Patrizia Giannoni, Margarita Arango-Lievano, Ines das Neves et al. · Neurobiology of Disease · 2016 · 143 citations · Full text

Alzheimer's Disease, Vascular Cognitive Disorder, Dementia +9

Serotonin: A New Hope in Alzheimer’s Disease?

Sylvie Claeysen, Joël Bockaert, Patrizia Giannoni · ACS Chemical Neuroscience · 2015 · 118 citations · Full text

Alzheimer's Disease, Medicine, Dementia +14

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · Proceedings of the National Academy of Sciences · 2014 · 116 citations · Full text

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT₄R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Christophe Rochais, Cédric Lecoutey, Florence Gaven et al. · Journal of Medicinal Chemistry · 2015 · 114 citations · Full text

Drug Target, Serotonergic Subtype 4, Neurochemical Biomarkers +19

The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain

Silvia Fossati, Patrizia Giannoni, María E. Solesio et al. · Neurobiology of Disease · 2015 · 101 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +14